XATOA

• Research type

  Research Study

• Full title

  XATOA – Xarelto + Acetylsalicylic Acid: Treatment patterns and Outcomes in patients with Atherosclerosis. A non-interventional study.

• IRAS ID

  260442

• Contact name

  Samuel Fatoba

• Contact email

  samuel.fatoba@bayer.com

• Sponsor organisation

  Bayer

• Duration of Study in the UK

  2 years, 1 months, 31 days

• Research summary

  Research Summary
  This is an international prospective study. It is non-interventional, meaning that data documented are routinely collected in daily practice from examinations or diagnostic tests; no additional examinations or tests need to be done.

  The study aims to collect real-world data about patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events that are treated with rivaroxaban to prevent atherothrombotic events (formation of arterial clots) and to describe outcomes of an antithrombotic regime based on dual pathway inhibition (rivaroxaban plus low-dose Aspirin) encountered in routine clinical practice.

  The study aims to recruit 10,000 patients worldwide, with 600-1000 planned for the UK.

  Summary of Results

  : https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fu2790089.ct.sendgrid.net%2Fls%2Fclick%3Fupn%3DXv3JSvJ-2B3M71ppf7N9agbZWluc0dOgH6w2ZqzVejRhSydh5Z20CA3Ejx79YrhCTyjNMYkCWaQhGyu7vf7IdDX72xmLXk-2FnlE5APXKILdlJdIQHonqx0UzzgbPRquzXOwMr-2FybS9L-2FVQhOYCuFdbeRIPs9nVAaVtZ5Mk-2F0g7NDbHNlCkgB8Zn10BC51aTBS2UuwE3efPHuD-2F1yJfyGsMTpA-3D-3DBlwK_E1aO2-2BZlVOSJJV-2FajQqskegTd6IRomHYTi-2Fbt8SH3YKsX2xUus24M25N45bolWayW3JzNFH7WkQ9KUJp0WfpfgeNf9gFvoqAlPO1Ui8R6Y9TL5VJftGjC2yoJ85f8T1h62gN8Sie9PCagN-2BUFZCTWP5TB-2BLyG9HVfbvCcVIBKghw1IS7ZoFiXzBaXnbVu0pg-2BSZGxXYboC6bdnO-2BNstz0Q-3D-3D&data=05%7C01%7Capprovals%40hra.nhs.uk%7Cca41107c33dc4b19c8a808da7eca3fcb%7C8e1f0acad87d4f20939e36243d574267%7C0%7C0%7C637961704363350290%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=J2y2qBRPVsbECrX0vakB0Z87hIl2k1GidkSPSktAkW0%3D&reserved=0

• REC name

  West Midlands - South Birmingham Research Ethics Committee

• REC reference

  19/WM/0137

• Date of REC Opinion

  14 Jun 2019

• REC opinion

  Further Information Favourable Opinion